Gladstone NOW: The Campaign Join Us on the Journey ✕
1 - 15 of 225 Results Clear All
Gladstone scientists created a new tool to understand the immune system’s inner workings when confronted with a virus.
Research (Publication) HIV/AIDS Virology Roan Lab
Melanie Ott talks about the ongoing measles outbreak, explains how vaccination can lower the risk of Alzheimer’s, and shares other positive “side effects” of vaccines.
Gladstone Experts Virology
KUSI News—Melanie Ott, director of the Gladstone Institute of Virology, explains that measles can have severe and lasting consequences in some people, especially children, and that the measles vaccine provides life-long protection in the vast majority of vaccinated people.
Gladstone Experts Virology Ott Lab
amfAR News—In an interview with the Foundation for AIDS Research, Melanie Ott, director of the Gladstone Institute of Virology, discusses the future of HIV research, and describes how lessons from the field have laid a strong foundation for fighting other viral diseases.
Gladstone Experts HIV/AIDS Virology Ott Lab
Salon—As bird flu spreads, rising egg prices aren’t the only concern. Melanie Ott, director of the Gladstone Institute of Virology, warns that we shouldn’t underestimate the potential of bird flu to cause serious illness in humans, and explains the potential of existing antiviral medications to help treat people who become infected.
Gladstone Experts Virology Ott Lab
Newsweek—As a second strain of bird flu has spread to dairy cows, Melanie Ott, director of the Gladstone Institute of Virology, explains why the jump is concerning, but reassures consumers that they should not be concerned about drinking pasteurized milk.
Gladstone Experts Virology Ott Lab
Avian influenza isn’t going away any time soon. But how serious is its threat to humans and what precautions are necessary?
News Release Virology Ott Lab
Researchers discovered that the presence of autoantibodies in the nose can help fight off the virus more effectively.
Research (Publication) COVID-19 Virology Roan Lab
Gladstone’s Magnus Hoffmann seeks to advance a new generation of more effective vaccines, improved drug delivery methods, and a greater overall understanding of vaccine-induced immune responses.
COVID-19 Data Science and Biotechnology Virology
Scientists say it may be possible to drive the virus into “deep latency” by targeting the cellular process of transcription, by which lingering HIV cells continue to produce viral components.
News Release Research (Publication) HIV/AIDS Virology Ott Lab
Virologist Sukrit Silas hopes to turn bacteria-killing viruses into new therapies that hold promise against even the most persistent superbugs.
News Release Profile Virology
Chemical & Engineering News—In a new study, scientists in Jennifer Doudna’s lab probe how viruses interfere with host signaling. Postdoctoral Fellow Jason Nomburg explains how they assembled a database of predicted structures of viral proteins, and used it to find the functions of previously mysterious proteins.
Gladstone Experts Virology Doudna Lab
A new study in Nature overturns the prevailing theory that blood clotting is merely a consequence of inflammation in COVID-19.
News Release Research (Publication) COVID-19 Neurological Disease Virology Akassoglou Lab
The Voice of San Francisco—Melanie Ott, director of the Gladstone Institute of Virology, answers questions about mpox at a time when many people are wondering about the virus’s ability to become another global pandemic, and also talks about how she and her team are contributing to the fight against it.
Gladstone Experts Virology Ott Lab
Scientists uncover an ancient immune-evading strategy shared by animal viruses and viruses that infect bacteria; findings may help in the development of new antiviral therapies
News Release Research (Publication) Data Science and Biotechnology Virology Doudna Lab CRISPR/Gene Editing
